Antimicrobial and Diagnostic Stewardship of the Novel β-Lactam/β-Lactamase Inhibitors for Infections Due to Carbapenem-Resistant Enterobacterales Species and <em>Pseudomonas aeruginosa</em>

Carbapenem-resistant Gram-negative bacterial infections are a major public health threat due to the limited therapeutic options available. The introduction of the new β-lactam/β-lactamase inhibitors (BL/BLIs) has, however, altered the treatment options for such pathogens. Thus, four new BL/BLI combi...

Full description

Bibliographic Details
Main Authors: Stefanos Ferous, Cleo Anastassopoulou, Vassiliki Pitiriga, Georgia Vrioni, Athanasios Tsakris
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/13/3/285